Call 413.540.1234 to
schedule an appointment
CONCERN/EAP: 413.534.2625
Billing questions? Call: 413.540.1212
CRISIS: 413.733.6661

Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
U.S. Better Able to Tackle Health Emergencies: ReportFirst Opioid Lawsuit Targeting Pharmacy Benefit ManagersMost Doctors' Offices Don't Offer Flexibility for UninsuredSafety Info for Opioids Found LackingNonoptimized Drug Therapy Costs More Than $500 Billion AnnuallyFDA Cracks Down on Caffeine-Loaded SupplementsCigarette Tax Hike Could Ease Poverty for Millions Worldwide: StudyCDC: Aggressive Action Needed to Contain Antibiotic ResistanceCould Medical Pot Help Curb the Opioid Abuse Crisis?Medical E-Records Not Without Risks: StudyHealth Groups Sue FDA to Speed Review of E-CigarettesEHR Usability Contributes to Possible Patient Harm EventsAHA: Solving the Dilemma of Not Enough HeartsUnchecked Air Pollution a Death Sentence for Millions: StudyPersonal Health Info Found in Recycling at Five HospitalsTask Force Issues Stronger Skin Cancer Prevention GuidelinesFDA Considers Lowering Nicotine Levels in CigarettesDoctors Facing Challenge to Help Needy While Protecting PracticesPharmacists Encouraged to Learn More About Herbal SupplementsBan Menthols to Help Some Smokers QuitStem Cell Clinics Pitch Pricey, Bogus 'Cures' for Knee PainMany Americans Think Docs Order Too Many Tests, MedsIs Herbal Drug Kratom a Health Friend or Foe?Early Studies Often Show Exaggerated Treatment EffectStrong Tobacco Laws May Weed Out Vapers, TooUnderstanding Rx Nonadherence Can Improve AdherenceBystander Use of Defib Device Doubles Chances of Surviving Cardiac ArrestNew Research Debunks Two Medical Marijuana MythsTake Early Clinical Trials With a Grain of SaltCould Hackers Target Heart Devices?Protecting Your Electronic Health RecordsAfter Another Shooting Tragedy, 'Stop the Bleed' Kits Urged for SchoolsPatients Want Physicians to Have Greater ConnectivityYour Tax Dollars Fund Research on Hundreds of New MedsFour Best Practices Outlined to Prevent Health Care CyberattacksMany Patients Know Too Little About Their MRI, CT Scans: StudyUnsafe Water Found in Faucets Across the U.S.Health Tip: Prevent Exposure to LeadHealth Tip: Online Pharmacies You Should AvoidDon't Count on an American to Do CPRPoll: Personal Beliefs Shouldn't Allow Doctors to Refuse to TreatFDA Says U.S. Will Now Produce Critical MRI ComponentPicking a New Primary Care DoctorUber, Lyft Rides May Not Help Boost Doc Visits for Poorer Patients2018 Immunization Schedule Issued for U.S. ChildrenA Hidden Source of 'Superbugs' in Hospitals?2018 Immunization Schedule Issued for U.S. AdultsTop Three Challenges Identified for Pharmacists in 2018Responding to Opioid Crisis, FDA Puts More Restrictions on ImodiumMonkey Deaths Prompt FDA Probe, New Controls on Animal Research
Questions and AnswersLinksBook Reviews
Related Topics

2018 Immunization Schedule Issued for U.S. Children


HealthDay News
Updated: Feb 6th 2018

new article illustration

TUESDAY, Feb. 6, 2018 (HealthDay News) -- The recommended childhood and adolescent immunization schedule for the United States has been issued for 2018 and published online Feb. 6 in Pediatrics.

Carrie L. Byington, M.D., from the American Academy of Pediatrics Committee on Infectious Diseases, and colleagues present the recommended childhood and adolescent immunization schedules for 2018, which have been revised to reflect current recommendations for vaccine use.

The researchers note that there have been no changes made to the immunization schedule. Two changes have been made to the catch-up immunization schedule: the rotavirus vaccine row has been modified to include the maximum ages for the first and last dose of the series. In addition, the polio vaccine rows clarify the schedule for children aged 4 years or older. Certain changes have been made to footnotes, including additional information regarding the timing of the birth dose of hepatitis B vaccine for infants with a birth weight of <2,000 grams. MenHibrix (bivalent meningococcal conjugate vaccine and Haemophilus influenzae type b conjugate vaccine) has been removed as it is no longer commercially available. The live attenuated influenza vaccine is not recommended for the 2017 to 2018 influenza season. Additionally, guidance is offered for a third dose of a mumps-containing vaccine in case of a mumps outbreak.

"The schedules are revised annually to reflect current recommendations for the use of vaccines licensed by the U.S. Food and Drug Administration," the authors write.

Abstract/Full Text